Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis

BACKGROUND: Interferon (IFN) beta-1a is an approved treatment for relapsing remitting multiple sclerosis (RRMS) and has been examined for use in secondary progressive multiple sclerosis (SPMS). However, no information regarding blood transcriptional changes induced by IFN treatment in SPMS patients...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Neurol
Asıl Yazarlar: Gurevich, Michael, Miron, Gadi, Falb, Rina Zilkha, Magalashvili, David, Dolev, Mark, Stern, Yael, Achiron, Anat
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654830/
https://ncbi.nlm.nih.gov/pubmed/26589141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-015-0495-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller